Skip to content

Effect of debittered and defatted fenugreek flakes on 24 hour blood glucose levels among adults with type 2 diabetes

Double blind, placebo controlled, cross-over clinical study to evaluate the effect of debittered and defatted fenugreek flakes on 24 hour glycemic response

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020654
Enrollment
20
Registered
2019-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Test diet (Isocaloric diet with Debittered and defatted fenugreek flakes): Iso caloric rice based diet with debittered defatted fenugreek flakes for 14 days. Control Intervention1: Cont

Sponsors

Indus Biotech PvtLtd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults with known diabetes Not on insulin treatment BMI 30kg/ m2 HbA1c between 7% to 11% On stable anti-hypertensive and lipid lower medication Volunteers willing to give informed consent

Exclusion criteria

Exclusion criteria: Type 1 diabetes subjects Females who are pregnant, lactating or planning to become pregnant Known food or drug allergy Subjects with any eating disorder or lactose intolerance chronic disease of heart, liver, kidney. Subject participating simultaneously or 3 months prior to screening in any other clinical trial. Subjects who are already consuming Fenugreek in soaked or powder form on daily basis.

Design outcomes

Primary

MeasureTime frame
Change in 24 hour incremental area under the blood glucose curve for 14 days assessed using flash glucose monitoringTimepoint: baseline (day 1) and End (Day 14) for each randomized diet.

Secondary

MeasureTime frame
To assess the changes in fasting blood glucose, insulin, and HbA1c from baseline. To determine changes in body weight from baseline Timepoint: baseline (day 1) and End (Day 14) for each randomized diet.

Countries

India

Contacts

Public ContactSudha Vasudevan

Madras Diabetes Research Foundation

s2r_7@mdrf.in04443968487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026